Cargando…

Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program

OBJECTIVE: Xpert MTB/RIF is recommended by the World Health Organization (WHO) as the initial tuberculosis (TB) diagnostic test in individuals suspected of HIV-associated TB. We sought to evaluate field implementation of Xpert among a cohort of HIV/TB co-infected individuals, including availability,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clouse, Kate, Blevins, Meridith, Lindegren, Mary Lou, Yotebieng, Marcel, Nguyen, Dung Thi, Omondi, Alfred, Michael, Denna, Zannou, Djimon Marcel, Carriquiry, Gabriela, Pettit, April
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300213/ https://www.ncbi.nlm.nih.gov/pubmed/28182705 http://dx.doi.org/10.1371/journal.pone.0171384

Ejemplares similares

Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration
por: Abo, Yao, et al.
Publicado: (2015)

Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014
por: Fritz, Cristin Q, et al.
Publicado: (2017)

Mortality Among People With HIV Treated for Tuberculosis Based on Positive, Negative, or No Bacteriologic Test Results for Tuberculosis: The IeDEA Consortium
por: Humphrey, John M, et al.
Publicado: (2020)

Mortality and losses to follow‐up among adolescents living with HIV in the IeDEA global cohort collaboration
por: Kariminia, Azar, et al.
Publicado: (2018)

IeDEA–WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development
por: Zaniewski, Elizabeth, et al.
Publicado: (2018)

Older Adults Accessing HIV Care and Treatment and Adherence in the IeDEA Central Africa Cohort
por: Newman, Jamie, et al.
Publicado: (2012)

Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium
por: Jesson, Julie, et al.
Publicado: (2020)

Integration of HIV care into maternal and child health services in the global IeDEA consortium
por: Humphrey, John, et al.
Publicado: (2023)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Implementation of “Treat‐all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey
por: Brazier, Ellen, et al.
Publicado: (2019)

Tobacco, alcohol and use of other recreational drugs within HIV-infected treated cohorts: the IeDEA West Africa collaboration
por: Jaquet, A, et al.
Publicado: (2009)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium
por: Patten, Gabriela, et al.
Publicado: (2020)

International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012–2019
por: Chammartin, Frédérique, et al.
Publicado: (2020)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration
por: Duda, Stephany N, et al.
Publicado: (2014)

Adult HIV care resources, management practices and patient characteristics in the Phase 1 IeDEA Central Africa cohort
por: Divaris, Kimon, et al.
Publicado: (2012)

Temporal Trends in the Characteristics of Children at Antiretroviral Therapy Initiation in Southern Africa: The IeDEA-SA Collaboration
por: Davies, Mary-Ann, et al.
Publicado: (2013)

Immunologic response in treatment-naïve HIV-2-infected patients: the IeDEA West Africa cohort
por: Balestre, Eric, et al.
Publicado: (2016)

Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration
por: Jesson, Julie, et al.
Publicado: (2019)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study
por: Donovan, Joseph, et al.
Publicado: (2020)

Comparison of Analytical Sensitivity (Limit of Detection) of Xpert MTB/RIF and Xpert MTB/RIF Ultra for Non-Sputum Specimens
por: Nielsen, Marisa C., et al.
Publicado: (2023)

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2013)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration
por: Morden, Erna, et al.
Publicado: (2016)

Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
por: Li, Hou-He, et al.
Publicado: (2020)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for diagnosis of tuberculous pleural effusion: A systematic review and comparative meta-analysis
por: Aggarwal, Ashutosh Nath, et al.
Publicado: (2022)

Head-to-head comparison of the efficacy of Xpert MTB/RIF Ultra and Xpert MTB/RIF for the diagnosis of tuberculous pleurisy: A systematic review and meta-analysis
por: Yu, Wenfeng, et al.
Publicado: (2022)

Trends in demographic and clinical characteristics and initiation of antiretroviral therapy among adult patients enrolling in HIV care in the Central Africa International epidemiology Database to Evaluate AIDS (CA‐IeDEA) 2004 to 2018
por: Adedimeji, Adebola A, et al.
Publicado: (2021)

Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS
por: Renner, Lorna A, et al.
Publicado: (2013)

Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017
por: Parcesepe, Angela M., et al.
Publicado: (2020)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis
por: Boulware, David R.
Publicado: (2013)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
por: Cayci, Yeliz Tanriverdi, et al.
Publicado: (2017)

Prevalence of Tuberculous Spondylodisciitis and Diagnostic Utility of Xpert MTB RIF
por: Ananthanarayanan, Rajalakshmi, et al.
Publicado: (2017)

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018)

Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
por: Antel, Katherine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m2tuqjp2r2thj9fpa0f38f7f1n